Fast Five Quiz: C3G Management

A. Brent Alper, Jr, MD, MPH

Disclosures

April 24, 2023

Currently available data report a high risk for recurrence of C3G in renal allografts for both DDD and C3GN patients.

Prediction of transplantation outcomes are complex. Important factors include sex, age, genotype, autoantibodies, and the current status of complement dysregulation. Age at transplantation seems to have a large effect on graft survival.

There are no specific treatment guidelines for C3G and current recommendations to guide decisions surrounding kidney transplantation are based on expert opinion and case reports, all of which support the value of genetic studies and complement evaluations prior to transplantation.

Learn more about kidney transplantation.

Editor's Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....